← Back to Search

Liver Education About Pain (LEAP) for Liver Cirrhosis

N/A
Waitlist Available
Led By Shari S Rogal, MD, MPH
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 6-12 months start-to-finish
Awards & highlights

Study Summary

This trial will test a behavior intervention to help patients with liver cirrhosis and chronic pain learn self-management skills.

Eligible Conditions
  • Liver Cirrhosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 6-12 months start-to-finish
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 6-12 months start-to-finish for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants attending ≥80% of intervention sessions
Overall Satisfaction

Trial Design

1Treatment groups
Experimental Treatment
Group I: LEAP Intervention ArmExperimental Treatment2 Interventions
Enrolled patients will participate in 12 weekly sessions led by a health coach to learn self-pain management tools and skills. In addition to 6 individual sessions and 6 optional group sessions, participants will complete activities from the LEAP workbook (provided after enrollment), as tracking is a key component of most pain-self management interventions and is intended to address self-regulation. All patients can continue to use other pain management strategies ("usual care") in order to mimic real-life conditions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Liver Education About Pain (LEAP)
2022
N/A
~30
Usual Care
1990
Completed Phase 4
~7700

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,719 Previous Clinical Trials
16,342,311 Total Patients Enrolled
3 Trials studying Liver Cirrhosis
104 Patients Enrolled for Liver Cirrhosis
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,563 Total Patients Enrolled
Shari S Rogal, MD, MPHPrincipal InvestigatorUniversity of Pittsburgh

Media Library

Liver Education About Pain (LEAP) Clinical Trial Eligibility Overview. Trial Name: NCT05128578 — N/A
Liver Cirrhosis Research Study Groups: LEAP Intervention Arm
Liver Cirrhosis Clinical Trial 2023: Liver Education About Pain (LEAP) Highlights & Side Effects. Trial Name: NCT05128578 — N/A
Liver Education About Pain (LEAP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05128578 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants is this study limited to?

"Affirmative. The information available on clinicaltrials.gov implies that the research project, which was initially advertised on March 14th 2022, is actively searching for participants to join their experiment. Forty individuals will be accepted at one medical centre."

Answered by AI

Are there any spots still available for the clinical trial?

"As confirmed by clinicaltrials.gov, this medical research is presently recruiting participants. The original posting was on March 14th 2022 and the details were amended most recently on April 5th 2022."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
How old are they?
18 - 65
What site did they apply to?
University of Pittsburgh Medical Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Improving Pain Management and Opioid Safety for Patients With Cirrhosis
Shari Rogal 2022. "Improving Pain Management and Opioid Safety for Patients With Cirrhosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05128578.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top